Literature DB >> 28801750

Cutaneous Drug Reactions in the Elderly.

James W S Young1,2, Neil H Shear3.   

Abstract

Cutaneous adverse drug reactions comprise a significant proportion of all adverse drug reactions. They may mimic other dermatologic or systemic illnesses and may cause significant morbidity or mortality. Seven morphologic groups encompass the most commonly encountered cutaneous drug reaction syndromes: exanthematous (maculopapular), dermatitic/eczematous, urticarial, pustular, blistering, purpuric, and erythrodermic. Drug reactions may have significant downstream consequences for the older individual.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28801750     DOI: 10.1007/s40266-017-0483-5

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   4.271


  204 in total

1.  SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.

Authors:  S Bastuji-Garin; N Fouchard; M Bertocchi; J C Roujeau; J Revuz; P Wolkenstein
Journal:  J Invest Dermatol       Date:  2000-08       Impact factor: 8.551

2.  Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.

Authors:  Christian Lange-Asschenfeldt; Renate Grohmann; Bernhard Lange-Asschenfeldt; Rolf R Engel; Eckart Rüther; Joachim Cordes
Journal:  J Clin Psychiatry       Date:  2009-06-16       Impact factor: 4.384

Review 3.  Drug photosensitivity, idiopathic photodermatoses, and sunscreens.

Authors:  E González; S González
Journal:  J Am Acad Dermatol       Date:  1996-12       Impact factor: 11.527

4.  Algorithm for the diagnosis of anaphylaxis and its validation using population-based data on emergency department visits for anaphylaxis in Florida.

Authors:  Laurel Harduar-Morano; Michael R Simon; Sharon Watkins; Carina Blackmore
Journal:  J Allergy Clin Immunol       Date:  2010-06-11       Impact factor: 10.793

5.  Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin.

Authors:  K Skandalis; M Spirova; G Gaitanis; A Tsartsarakis; I D Bassukas
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-04-06       Impact factor: 6.166

6.  Outcome for older burn patients.

Authors:  V McGill; A Kowal-Vern; R L Gamelli
Journal:  Arch Surg       Date:  2000-03

Review 7.  Phototoxicity and photoallergy.

Authors:  J H Epstein
Journal:  Semin Cutan Med Surg       Date:  1999-12

8.  High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.

Authors:  Jinbo Chen; Baoxi Wang; Yueping Zeng; Haoxiang Xu
Journal:  Eur J Dermatol       Date:  2010-10-15       Impact factor: 3.328

9.  Clinical resemblance of widespread bullous fixed drug eruption to Stevens-Johnson syndrome or toxic epidermal necrolysis: report of two cases.

Authors:  Tzu-Kai Lin; Mark Ming-Long Hsu; Julia Yu-Yun Lee
Journal:  J Formos Med Assoc       Date:  2002-08       Impact factor: 3.282

Review 10.  Frailty in elderly people.

Authors:  Andrew Clegg; John Young; Steve Iliffe; Marcel Olde Rikkert; Kenneth Rockwood
Journal:  Lancet       Date:  2013-02-08       Impact factor: 79.321

View more
  2 in total

Review 1.  Eczematous Drug Eruptions.

Authors:  Amy E Blum; Susan Burgin
Journal:  Am J Clin Dermatol       Date:  2021-02-15       Impact factor: 7.403

2.  An inventory of medicinal products causing skin rash: Clinical and regulatory lessons.

Authors:  Robert Ancuceanu; Mihaela Dinu; Florentina Furtunescu; Daniel Boda
Journal:  Exp Ther Med       Date:  2019-07-31       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.